Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial
2023; Nature Portfolio; Volume: 29; Issue: 12 Linguagem: Inglês
10.1038/s41591-023-02309-4
ISSN1546-170X
AutoresHatem Soliman, Deanna Hogue, Hyo S. Han, Blaise Mooney, Ricardo Costa, Marie Catherine Lee, Bethany L. Niell, Angela Williams, Alec Chau, Shannon Falcon, Aixa Soyano, Avan Armaghani, Nazanin Khakpour, R. Jared Weinfurtner, Susan Hoover, John V. Kiluk, Christine Laronga, Marilin Rosa, Hung T. Khong, Brian J. Czerniecki,
Tópico(s)Virus-based gene therapy research
Referência(s)